Efficacy and PK of turoctocog alfa pegol in patients with severe haemophilia A: Results from 4 clinical trials

被引：0
|
作者：
Tiede, A. [1 ]
Meunier, S. [2 ]
Chowdary, P. [3 ,4 ]
Lentz, S. R. [5 ]
Kavakli, K. [6 ]
Hampton, K. [7 ]
Oldenburg, J. [8 ]
Driessler, F. [9 ]
Santagostino, E. [10 ]
Clausen, W. [11 ]
机构：
[1] Hannover Med Sch MHH, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany
[2] Hosp Civils Lyon, Grp Hosp Est, Unite Hemostase Clin, Lyon, France
[3] Royal Free Hosp, Katherine Dormandy Haemophilia Ctr, London, England
[4] Royal Free Hosp, Thrombosis Unit, London, England
[5] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA 52242 USA
[6] Ege Univ, Childrens Hosp, Dept Hematol, Izmir, Turkey
[7] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England
[8] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[9] Novo Nordisk Hlth Care AG, Global Med Affairs Biopharma, Zurich, Switzerland
[10] Maggiore Hosp Polyclin, IRCCS Ca Granda Fdn, Angelo Bianchi Bonomi Ctr Haemophilia & Thrombosi, Milan, Italy
[11] Novo Nordisk AS, Soborg, Denmark
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P012
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of turoctocog alfa pegol during orthopaedic surgery in patients with severe haemophilia A
    Hampton, K.
    Clausen, W. H. O.
    Landorph, A.
    Santagostino, E.
    Chowdary, P.
    Escobar, M.
    HAEMOPHILIA, 2019, 25 : 4 - 5
  • [2] Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials
    Santagostino, E.
    Lentz, S. R.
    Misgav, M.
    Brand, B.
    Chowdary, P.
    Savic, A.
    Kilinc, Y.
    Amit, Y.
    Amendola, A.
    Solimeno, L. P.
    Saugstrup, T.
    Matytsina, I.
    HAEMOPHILIA, 2015, 21 (01) : 34 - 40
  • [3] Safety of Turoctocog Alfa for The Prevention and Treatment of Bleeds in Patients with Haemophilia A: Results for The Guardian™ Clinical Trials
    Matytsina, I.
    Janic, D.
    Lejniece, S.
    Santagostino, E.
    HAEMOPHILIA, 2015, 21 : 33 - 33
  • [4] Impact of severe haemophilia A on patients' health status: results from the guardian™ clinical trial of turoctocog alfa (NovoEight®)
    Ozelo, M.
    Chowdary, P.
    Regnault, A.
    Busk, A. K.
    HAEMOPHILIA, 2015, 21 (04) : 451 - 457
  • [5] Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial
    Yaish, Hassan
    Matsushita, Tadashi
    Belhani, Meriem
    Jimenez-Yuste, Victor
    Kavakli, Kaan
    Korsholm, Lars
    Matytsina, Irina
    Philipp, Claire
    Reichwald, Kirsten
    Wu, Runhui
    HAEMOPHILIA, 2020, 26 (01) : 64 - 72
  • [6] Correlation between ABR and PK parameters in patients with severe haemophilia A receiving Turoctocog alfa (NOVOEIGHT®) for prophylaxis
    Jimenez-Yuste, V
    Lejniece, S.
    Rosholm, A.
    Tripkovic, N.
    Santagostino, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 352 - 353
  • [7] Pharmacokinetic analysis in patients with haemophilia A in prophylaxis with turoctocog alfa pegol in one centre in spain
    Benitez Hidalgo, O.
    Camarillas Carmona, S.
    Juarez Gimenez, J. C.
    HAEMOPHILIA, 2024, 30 : 112 - 112
  • [8] Effect of turoctocog alfa on quality of life of children, adolescents and adults with haemophilia A: results from two clinical trials
    Santagostino, E.
    Lentz, S.
    Iorio, A.
    Busk, A. K.
    Adab-Franch, L.
    Meunier, J.
    Regnault, A.
    HAEMOPHILIA, 2013, 19 : 23 - 23
  • [9] Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics
    Kulkarni, R.
    Karim, F. A.
    Glamocanin, S.
    Janic, D.
    Vdovin, V.
    Ozelo, M.
    Rageliene, L.
    Carboni, E.
    Laguna, P.
    Dobaczewski, G.
    Seremetis, S.
    Lindblom, A.
    Santagostino, E.
    HAEMOPHILIA, 2013, 19 (05) : 698 - 705
  • [10] Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy
    Lentz, S. R.
    Misgav, M.
    Ozelo, M.
    Salek, S. Z.
    Veljkovic, D.
    Recht, M.
    Cerqueira, M.
    Tiede, A.
    Brand, B.
    Mancuso, M. E.
    Seremetis, S.
    Lindblom, A.
    Martinowitz, U.
    HAEMOPHILIA, 2013, 19 (05) : 691 - 697
12345